Home
Dashboard
Curated content
Startups & Scaleups
SMEs & Corporates
Investors
Funding rounds
Accelerators
Universities
Governments & Non-profits
More organizations
Matching tool
Companies
Gero
Save
Gero
AI+physics driven drug discovery company focused on therapies targeting aging and age-related diseases.
Launch date
2018
Employees
51-200 people
Market cap
-
Enterprise valuation
€22—33m
(Dealroom.co estimates Oct 2023.)
Singapore Singapore (HQ)
View more
https://gero.ai/
https://twitter.com/hacking_aging
https://www.facebook.com/geroscience
https://www.linkedin.com/company/gero/
B2B
manufacturing
health
biotechnology
artificial intelligence
hard tech
biotechnology
biotech and pharma
core ai
ai applications
drug development
ai drug discovery
longevity
modeling
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Gero funding
Gero investors
Edit
Date
Investors
Amount
Round
-
Fusion.xyz
Plug and Play
N/A
-
May 2019
Bulba Ventures
N/A
Seed
Aug 2020
*
Bulba Ventures
$2.2m
Series A
Oct 2023
*
Leo Lozner
VitaDAO
Melnichek Investments
$6.0m
Series A
Total Funding
€7.5m
Related Content
Recent News about Gero
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Gero
Edit
Life & Health Metrics
